K Schwab, D Lauer, M Magbagbeolu, F Theuring… - Brain Research …, 2024 - Elsevier
In clinical trials for Alzheimer's disease (AD), hydromethylthionine mesylate (HMTM) showed
reduced efficacy when administered as an add-on to symptomatic treatments, while it …